Special Issue on ELISPOT and ELISA

The enzyme-linked immunospot assay (ELISPOT) resembles the enzyme-linked immunosorbent assay (ELISA). In both techniques pairs of antibodies are used: primary antibodies and secondary antibodies. Beside this, however, there are more differences than similarities. Thanks to these differences, ELISPOT overcomes certain limitations of ELISA. Moreover, combining both techniques in one experiment supplies additional information, e.g. it is possible to calculate the mean production of a cytokine by single stimulated cell.

In this special issue, we intend to invite front-line researchers and authors to submit original researches and review articles on exploring ELISPOT and ELISA. Potential topics include, but are not limited to:

• ELISA types
• ELISPOT in cancer and drug discovery
• ELISPOT advantages
• ELISPOT principle
• ELISA principle
• ELISA advantages
• ELISA reagents
• ELISA detection strategies

Authors should read over the journal’s Authors’ Guidelines carefully before submission. Prospective authors should submit an electronic copy of their complete manuscript through the journal at Paper Submission System.

Please kindly specify the “Special Issue” under your manuscript title. The research field “Special Issue – ELISPOT and ELISA” should be selected during your submission.

Special Issue timetable:

Guest Editor:

For further questions or inquiries

Please contact Editorial Assistant at

abb@scirp.org